Approval · Notice of Compliance 17532 · 2015
SANTYL: Notice of Compliance 17532
Issued December 3, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17532
- Date
- December 3, 2015
- Company
- Smith & Nephew, Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New master cell bank
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SANTYL | Not yet assigned | — |
Medicinal ingredients
- COLLAGENASE 250 UNIT per G